MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about compliance certificate

08 Apr 2020 Evaluate

Glaxosmithkline Pharmaceuticals has informed that in compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, the Company enclosed a copy of the Certificate received from KFin Technologies, the Registrar and share Transfer Agent of the Company, for the quarter ended 31st March 2020.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..